Buspirone Hydrochloride 30mg Tablets, Non-Fasting
Clinical trial NCT00840398 · COMPLETED
Trial details
- NCT number
- NCT00840398
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2001-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.